The results come as Pfizer scrambles to stabilize its business and win back Wall Street’s favor following the rapid decline in demand for its Covid products.
from Business News https://ift.tt/yM9gODc
Pfizer beats earnings estimates, hikes full-year outlook as drugmaker cuts costs
July 30, 2024
0
